2025 Speakers | Kisaco Research
  • Author:

    Shah Nawaz

    Vice President & Chief Technology Officer
    Regeneron

    Shah Nawaz

    Vice President & Chief Technology Officer
    Regeneron
  • Author:

    David Hallett

    Chief Scientific Officer
    Recursion

    David Hallett

    Chief Scientific Officer
    Recursion
  • Author:

    Philip Tagari

    Chief Scientific Officer
    Insitro

    Philip Tagari

    Chief Scientific Officer
    Insitro
  • Author:

    Morten Sogaard

    Senior Vice President & Head, Astellas Innovation Lab
    Astellas Pharma

    Morten Sogaard

    Senior Vice President & Head, Astellas Innovation Lab
    Astellas Pharma
  • Author:

    Shane Lewin

    Vice President, AI & ML
    GSK

    Shane Lewin

    Vice President, AI & ML
    GSK
  • Author:

    Justin Scheer

    Vice President, In Silico Discovery
    Johnson & Johnson Innovative Medicine

    Justin Scheer

    Vice President, In Silico Discovery
    Johnson & Johnson Innovative Medicine
  • Author:

    Petrina Kamya

    President & Global Head, AI Platforms
    Insilico Medicine

    Petrina Kamya

    President & Global Head, AI Platforms
    Insilico Medicine
  • Author:

    Claire Zhao

    Associate Director, AI/ML & Quantitative & Digital Sciences
    PFIZER

    Claire Zhao

    Associate Director, AI/ML & Quantitative & Digital Sciences
    PFIZER
  • Author:

    Zoran Krunic

    Principal Product Manager
    Amgen

    Since joining Amgen R&D in 2018, Zoran Krunic has been at the forefront of applying Machine Learning to enhance patient outcomes and streamline clinical trial enrollment processes, utilizing comprehensive Electronic Health Records and clinical datasets. His pioneering work in the Quantum Machine Learning space, in collaboration with IBM's Quantum team, has been instrumental in integrating machine learning with quantum computing through IBM’s Qiskit platform.

    Prior to his tenure at Amgen, Zoran developed Machine Learning algorithms at Optum to predict hardware and software failures within complex enterprise architectures. He has a strong background in data engineering and systems development, having contributed significantly to large-scale projects at renowned organizations such as Capital Group and ARCO Petroleum.

    In his current full and part-time endeavors, Zoran is leading the efforts in embracing generative AI technologies, with a particular focus on OpenAI's GPT and Anthropic's Claude-2 models. His work is focused on prompt engineering and its application to code generation, advanced document analysis, and process management, with a commitment to ethical AI practices and data privacy.

    A recognized voice in quantum computing circles, Zoran is a regular presenter at industry conferences and has served on numerous panels discussing the integration of quantum computing and generative AI within the Health Sciences sector.

    With a Master of Science in Electrical Engineering & Computer Science, Zoran continues to explore and contribute to the evolving relationship between quantum computing and artificial intelligence, fostering groundbreaking advancements in healthcare technology.

    Zoran Krunic

    Principal Product Manager
    Amgen

    Since joining Amgen R&D in 2018, Zoran Krunic has been at the forefront of applying Machine Learning to enhance patient outcomes and streamline clinical trial enrollment processes, utilizing comprehensive Electronic Health Records and clinical datasets. His pioneering work in the Quantum Machine Learning space, in collaboration with IBM's Quantum team, has been instrumental in integrating machine learning with quantum computing through IBM’s Qiskit platform.

    Prior to his tenure at Amgen, Zoran developed Machine Learning algorithms at Optum to predict hardware and software failures within complex enterprise architectures. He has a strong background in data engineering and systems development, having contributed significantly to large-scale projects at renowned organizations such as Capital Group and ARCO Petroleum.

    In his current full and part-time endeavors, Zoran is leading the efforts in embracing generative AI technologies, with a particular focus on OpenAI's GPT and Anthropic's Claude-2 models. His work is focused on prompt engineering and its application to code generation, advanced document analysis, and process management, with a commitment to ethical AI practices and data privacy.

    A recognized voice in quantum computing circles, Zoran is a regular presenter at industry conferences and has served on numerous panels discussing the integration of quantum computing and generative AI within the Health Sciences sector.

    With a Master of Science in Electrical Engineering & Computer Science, Zoran continues to explore and contribute to the evolving relationship between quantum computing and artificial intelligence, fostering groundbreaking advancements in healthcare technology.

  • Author:

    Chirag Sacher

    Director, Portfolio Innovation
    Novartis

    Chirag Sacher

    Director, Portfolio Innovation
    Novartis
  • Author:

    Ari Allyn-Feuer

    Director, AI Intelligence Product
    GSK

    Ari Allyn-Feuer

    Director, AI Intelligence Product
    GSK
  • Author:

    Mark Adams

    Venture Capital Partner
    Two Bear Capital

    Mark Adams

    Venture Capital Partner
    Two Bear Capital
  • Author:

    Arvind Rao

    Associate Professor, Computational Medicine & Bioinformatics
    University of Michigan

    Arvind Rao

    Associate Professor, Computational Medicine & Bioinformatics
    University of Michigan
  • Author:

    Zhiyong (Sean) Xie

    Vice President & Head, AI & Data Science
    Xellarbio

    Zhiyong (Sean) Xie

    Vice President & Head, AI & Data Science
    Xellarbio
  • Author:

    Adam Root

    Vice President & Head, Protein Sciences
    Generate Biomedicines

    Adam Root

    Vice President & Head, Protein Sciences
    Generate Biomedicines
  • Author:

    Ethan Pickering

    Head, Data Science & ML Research
    Bayer

    Ethan Pickering

    Head, Data Science & ML Research
    Bayer
  • Author:

    Virginia Savova

    Senior Director, Head Cell-Targeted Precision Medicine
    AstraZeneca

    Virginia Savova

    Senior Director, Head Cell-Targeted Precision Medicine
    AstraZeneca
  • Author:

    Peter Henstock

    Senior Machine Learning Engineer
    Incyte

    Peter Henstock

    Senior Machine Learning Engineer
    Incyte
  • Author:

    Nevin Gerek Ince

    Director, Data & Solutions Engineering
    Novo Nordisk

    Nevin Gerek Ince

    Director, Data & Solutions Engineering
    Novo Nordisk
  • Author:

    Daniyal Hussain

    Executive Director, Technology Business Development
    GSK

    Daniyal Hussain

    Executive Director, Technology Business Development
    GSK
  • Author:

    Michael Dandrea

    Principal Data Scientist
    Genentech

    Michael Dandrea

    Principal Data Scientist
    Genentech
  • Author:

    Preeya Boppana

    Associate Director, Manufacturing Science & Technology
    AstraZeneca Global Biologics

    Preeya Boppana

    Associate Director, Manufacturing Science & Technology
    AstraZeneca Global Biologics
  • Author:

    Yves Fomekong Nanfack

    PhD, Executive Director, Head, End to End AI Foundations, Large Molecules Research
    Sanofi

    Yves Fomekong Nanfack

    PhD, Executive Director, Head, End to End AI Foundations, Large Molecules Research
    Sanofi
  • Author:

    Lingling Shen

    Associate Director, Discovery Sciences
    Novartis

    Lingling Shen

    Associate Director, Discovery Sciences
    Novartis
  • Author:

    Satarupa Mukherjee

    R&D Leader, AI/ML (Digital Pathology)
    Roche

    Satarupa Mukherjee

    R&D Leader, AI/ML (Digital Pathology)
    Roche
  • Author:

    Yorgos Psarellis

    Senior Computational & Machine Learning Scientist
    Sanofi

    Yorgos Psarellis

    Senior Computational & Machine Learning Scientist
    Sanofi
  • Author:

    Kiran Nistala

    Head, Functional Genomics
    Alkermes

    Kiran Nistala

    Head, Functional Genomics
    Alkermes
  • Author:

    Ashwini Ghogare

    Head of AI & Automation in Drug Discovery
    MilliporeSigma

    Ashwini Ghogare

    Head of AI & Automation in Drug Discovery
    MilliporeSigma
  • Author:

    Jason Cross

    Institute Director, Structural & Computational Drug Design
    MD Anderson Cancer Center

    Jason Cross

    Institute Director, Structural & Computational Drug Design
    MD Anderson Cancer Center
  • Author:

    Monica Wang

    Head, Biologics & Novel Modality Discovery Capabilities & Products, Scientific Informatics
    Takeda

    Monica Wang

    Head, Biologics & Novel Modality Discovery Capabilities & Products, Scientific Informatics
    Takeda
  • Author:

    Shameer Khader

    Executive Director, Precision Medicine & Computational Biology
    Sanofi

    Shameer Khader

    Executive Director, Precision Medicine & Computational Biology
    Sanofi
  • Author:

    David Kombo

    Principal Scientist
    Sanofi

    David Kombo

    Principal Scientist
    Sanofi
  • Author:

    Michael Steinbaugh

    Director, Data, AI & Genome Sciences
    Merck

    Michael Steinbaugh

    Director, Data, AI & Genome Sciences
    Merck
  • Author:

    Hans Bitter

    Head, Computational Sciences
    Takeda

    Hans Bitter

    Head, Computational Sciences
    Takeda
  • Author:

    Qi Song

    Principal Scientist, Predictive Biology & AI
    Bristol Myers Squibb

    Qi Song

    Principal Scientist, Predictive Biology & AI
    Bristol Myers Squibb
  • Author:

    Yue-Wang Webster

    Vice President, Model Driven Drug Discovery Platforms
    Eli Lilly

    Yue-Wang Webster

    Vice President, Model Driven Drug Discovery Platforms
    Eli Lilly
  • Author:

    Pavan Choksi

    Partner
    Arkitek Ventures

    Pavan Choksi

    Partner
    Arkitek Ventures
  • Author:

    Ramila Pieres

    Global Head, Data Management, ML/AI, MSAT
    Sanofi

    Ramila Pieres

    Global Head, Data Management, ML/AI, MSAT
    Sanofi
  • Author:

    Maria Florez

    Senior Consultant
    Tufts

    Maria Florez

    Senior Consultant
    Tufts
  • Author:

    Nathan Stover

    PhD Student, Chemical Engineering
    Massachusetts Institute of Technology

    Nathan Stover

    PhD Student, Chemical Engineering
    Massachusetts Institute of Technology
  • Author:

    Alexander Horspool

    Associate Director, Innovation, Biotherapeutics Discovery
    Boehringer Ingelheim

    Alexander Horspool

    Associate Director, Innovation, Biotherapeutics Discovery
    Boehringer Ingelheim
  • Author:

    Gregory Goldmacher

    Assistant Vice President, Clinical Research, Head, Imaging
    Merck

    Gregory Goldmacher

    Assistant Vice President, Clinical Research, Head, Imaging
    Merck
  • Author:

    Shruti Vij

    Associate Director, Data Analytics & Modeling
    Takeda

    Shruti Vij

    Associate Director, Data Analytics & Modeling
    Takeda
  • Author:

    Benjamin Stevens

    Director, CMC Policy
    GSK

    Benjamin Stevens

    Director, CMC Policy
    GSK
  • Author:

    Veera Padmanabhan

    Head, Manufacturing Science & Technology
    AstraZeneca

    Veera is currently managing a team of 40+ scientists, establishing robotics, lab automation predictive analytics and advanced chemometrics in next generation biologics manufacturing at AstraZeneca. He has 25+ years of experience, with expertise crossing R&D, manufacturing operations and supply chain.

    Veera Padmanabhan

    Head, Manufacturing Science & Technology
    AstraZeneca

    Veera is currently managing a team of 40+ scientists, establishing robotics, lab automation predictive analytics and advanced chemometrics in next generation biologics manufacturing at AstraZeneca. He has 25+ years of experience, with expertise crossing R&D, manufacturing operations and supply chain.

  • Author:

    Irfan Ali Mohammed

    Director, CMC
    Alexion Pharmaceuticals

    Irfan Ali Mohammed

    Director, CMC
    Alexion Pharmaceuticals
  • Author:

    Sreyoshi Sur

    Former Scientist, Molecular Engineering & Modeling
    Moderna

    Sreyoshi Sur

    Former Scientist, Molecular Engineering & Modeling
    Moderna
  • Author:

    Xiao Li

    Principal Scientist
    Sanofi

    Xiao Li

    Principal Scientist
    Sanofi
  • Author:

    Yi Hong

    Senior Consultant
    Gilead

    Yi Hong

    Senior Consultant
    Gilead
  • Author:

    Dirk Van Hyfte

    Co-Founder
    IPA

    Dirk Van Hyfte

    Co-Founder
    IPA
  • Author:

    Wolfgang Colsman

    Founder & CEO
    Zontal

    Wolfgang Colsman

    Founder & CEO
    Zontal
  • Author:

    Jack Geremia

    CEO
    Matterworks

    Jack Geremia

    CEO
    Matterworks
  • Author:

    Rameez Chatni

    Global Director, AI Solutions, Pharmaceutical & Life Sciences
    Cloudera

    Rameez Chatni

    Global Director, AI Solutions, Pharmaceutical & Life Sciences
    Cloudera